Annals of Emergency Medicine
Volume 44, Issue 2 , Pages 105-107 , August 2004

Can steel heal a compartment syndrome caused by rattlesnake venom?

  • Richard C. Dart, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Richard C. Dart, MD, PhD, Rocky Mountain Poison and Drug Center, 777 Bannock Street, MC 0180, Denver, CO 80204; 303-739-1100, fax 303-739-1443

References 

  1. Glass TG. Early debridement in pit viper bites. JAMA. 1976;235:2513–2515
  2. Cawrse NH, Inglefield CJ, Hayes C, et al.  A snake in the clinical grass: late compartment syndrome in a child bitten by an adder. Br J Plastic Surg. 2002;55:434–435
  3. Gold BS, Barish RA, Dart RC, et al.  Resolution of compartment syndrome after rattlesnake envenomation utilizing non-invasive measures. J Emerg Med. 2003;24:285–288
  4. Rosen PB, Leiva JI, Ross CP. Delayed antivenom treatment for a patient after envenomation by Crotalus atrox. Ann Emerg Med. 2000;35:86–88
  5. Grace TG, Omer GE. The management of upper extremity pit viper wounds. J Hand Surg. 1980;5:168–177
  6. Stewart RM, Page CP, Schwesinger WH, et al.  Antivenin and fasciotomy/debridement in the treatment of the severe rattlesnake bite. Am J Surg. 1989;158:543–547
  7. Garfin SR, Castilonia RR, Mubarak SJ, et al.  The effect of antivenin on intramuscular pressure elevations induced by rattlesnake venom. Toxicon. 1985;23:677–680
  8. Garfin SR, Castilonia RR, Mubarak SJ, et al.  Rattlesnake bites and surgical decompression: results using a laboratory model. Toxicon. 1984;22:177–182
  9. Tanen DA, Danish DC, Clark RF. Crotalidae polyvalent immune fab antivenom limits the decrease in perfusion pressure of the anterior leg compartment in a porcine crotaline envenomation model. Ann Emerg Med. 2003;41:384–390
  10. Tanen DA, Danish DC, Grice GA, et al.  Fasciotomy worsens the amount of myonecrosis in a porcine model of crotaline envenomation. Ann Emerg Med. 2004;44:99–104
  11. Heard K, Yip L, Dart RC. Reporting of animal research methods: Are rigorous study methods reported?. [abstract] J Toxicol Clin Toxicol. 1998;36:490

☆ The Rocky Mountain Poison and Drug Center receives funding from Fougera, a pharmaceutical company that makes antivenom.

☆☆ Reprints not available from the author.

PII: S0196-0644(04)00280-X

doi: 10.1016/j.annemergmed.2004.03.013

Annals of Emergency Medicine
Volume 44, Issue 2 , Pages 105-107 , August 2004

Article Tools

* Image Usage & Resolution